Logo

American Heart Association

  105
  0


Final ID:

Discussant: RSQ-777-02

  • Testani, Jeffrey  ( YALE , Guilford , Connecticut , United States )
  • Ommen, Steve  ( MAYO CLINIC , Rochester , Minnesota , United States )
  • Patel, Ravi  ( Northwestern University , Chicago , Illinois , United States )
  • Author Disclosures:
    Jeffrey Testani: DO NOT have relevant financial relationships | Steve Ommen: DO have relevant financial relationships ; Advisor:Cytokinetics:Past (completed) | Ravi Patel: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Building on the 4 Pillars: Novel Trials of Medical Therapy for Heart Failure

Monday, 11/18/2024 , 08:00AM - 09:15AM

Late-Breaking Science

More abstracts on this topic:
Novel Bumetanide Nasal Spray (BNS) Demonstrates Safety, Tolerability, and Equivalent Efficacy Compared to Intravenous and Oral Bumetanide

Kolski Brian, Bensimhon Daniel, Adler Eric, Kapur Navin, Lala Anuradha, Macaluso Gregory, Hajduczok Alexander, Neutel Joel

Discussant: The SARAH Trial

Lopez-fernandez Teresa, Ky Bonnie

More abstracts from these authors:
The ICAM1 p.K56M HFpEF Risk Variant and Measures of Adiposity

Aneja Anushree, Culler Kasen, Ding Jingzhong, Raffield Laura, Ekunwe Lynette, Taylor Kent, Shah Sanjiv, Rasmussen-torvik Laura, Patel Ravi

Implementing Heart Failure GDMT in Advanced CKD: Key Considerations

Covic Adrian, Bali Atul, Testani Jeffrey, Tuttle Katherine, Bansal Nisha

You have to be authorized to contact abstract author. Please, Login
Not Available